Keywords: Ampio Pharma, Optina, Danazol, Diabetic macular edema, Registration studies

Positive update on Ampio oral eye drug Optina

Article | 20 March 2012

Colorado, USA-based biopharma firm Ampio Pharmaceuticals,(Nasdaq: AMPE) yesterday announced that it completed the planned interim review of the first 50% ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Ampio Pharmaceuticals

Go to company listing

Related Drugs

Optina

Danazol

Go to drug listing